¹Manuel Aparicio-Alonso, ²Carlos A. Domínguez-Sánchez, ³Marina Banuet-Martínez

¹,²,³Centro Médico Jurica, Querétaro, México

To date, there is no effective prophylactic agent to prevent COVID-19. However, the development of symptoms similar to covid19 could be prevented with an aqueous solution of chlorine dioxide (ClO2). This retrospective study evaluated the effectiveness of an aqueous solution of ClO2 (CDS) as a prophylactic agent in 1,163 family members living with positive/suspected COVID19 patients. Prophylactic treatment consisted of 0.0003% chlorine dioxide solution (CDS) orally for at least fourteen days. Family members in whom no reports of the development of covid19-like symptoms were found in the medical history were considered successful cases. The efficacy of CDS in preventing covid19-like symptoms was 90.4% (1,051 of 1,163 relatives did not report any symptoms). The comorbidities, sex and severity of the illness of the sick patient did not contribute to the development of symptoms similar to covid19 (P = 0.092, P = 0.351 and P = 0.574, respectively). However, older relatives were more likely to develop covid19-like symptoms (ORa = 4.22, P = 0.002). There was no evidence of alterations in blood parameters or in the QTc interval in relatives who consumed CDS. The recent findings regarding Chlorine Dioxide justify designing clinical trials to assess its efficacy for preventing SARS-CoV-2 infection.

Chlorine Dioxide, prophylaxis, COVID19, Pandemic

1) Agrawal, Sumita, Akhil Dhanesh Goel, and Nitesh Gupta. 2020. “Emerging Prophylaxis Strategies against COVID-19.” Monaldi Archives for Chest Disease 90:169–72.

2) Alam, Mohammed Tarek, Rubaiul Murshed, Pauline Francisca Gomes, Zafor Md. Masud, Sadia Saber, Mainul Alam Chaklader, Fatema Khanam, Monower Hossain, Abdul Basit Ibne Momen Momen, Naz Yasmin, Rafa Faaria Alam, Amrin Sultana, and Rishad Choudhury Robin. 2020. “Ivermectin as Pre-Exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study.” European Journal of Medical and Health Sciences 2(6):1–5.

3) Bryant, Andrew, Theresa Lawrie, Edmund Fordham, Mitchell Scott, Sarah Hill, and Tony Tham. 2021. “Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis.” PREPRINT (Version 1) Available at Research Square 1–25.

4) Chorin, Ehud, Lalit Wadhwani, Silvia Magnani, Matthew Dai, Roi Bar-cohen, Edward Kogan, Chirag Barbhaiya, Anthony Aizer, Douglas Holmes, Scott Bernstein, Michael Spinelli, David S. Park, Carugo Stefano, and Larry A. Chinitz. 2020. “QT Interval Prolongation and Torsade de Pointes in Patients with COVID-19 Treated with Hydroxychloroquine/Azithromycin.” Heart Rhythm 17:1425–33.

5) Christos-Konstantinos, Antoniou, Dilaveris Polychronis, Manolakou Panagiota, Galanakos Spyridon, Magkas Nikolaos, Gatzoulis Konstantinos, and Tousoulis Dimitrios. 2017. “QT Prolongation and Malignant Arrhythmia: How Serious a Problem?” European Cardiology Review 12(2):112–20.

6) Dahlberg, Pia, Ulla Britt Diamant, Thomas Gilljam, Annika Rydberg, and Lennart Bergfeldt. 2021. “QT Correction Using Bazett’s Formula Remains Preferable in Long QT Syndrome Type 1 and 2.” Annals of Noninvasive Electrocardiology 26:e12804.

7) Díaz Piedra, Pablo, Gabriela Olay Fuentes, Ricardo Hernández Gómez, Daniel Cervantes-Villagrana, José Miguel Presno Bernal, and Luz Elena Alcántara Gómez. 2012. “Determinación de Los Intervalos de Referencia de Biometría Hemática En Población Mexicana.” Revista Latinoamericana de Patología Clínica y Medicina de Laboratorio 59(4):243–50.

8) Elgazzar, Ahmed, Basma Hany, Shaimaa Abo Youssef, Mohy Hafez, Hany Moussa, and Abdelaziz Eltaweel. 2020. “Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic.” PREPRINT (Version 2) Available at Research Square 1–13.

9) Galvañ, Vicente Giner, María Rosa Oltra, Diego Rueda, María José Esteban, and Josep Redón. 2007. “Severe Acute Hepatitis Related to Hydroxychloroquine in a Woman with Mixed Connective Tissue Disease.” Clinical Rheumatology 26(6):971–72.

10) Gupta, Dhyuti, Ajaya Kumar Sahoo, and Alok Singh. 2020. “Ivermectin: Potential Candidate for the Treatment of Covid 19.” Brazilian Journal of Infectious Diseases 24(4):369–71.

11) Insignares-Carrione, Eduardo, Blanca Bolano Gómez, and Andreas Ludwig Kalcker. 2020. “Chlorine Dioxide in COVID-19: Hypothesis about the Possible Mechanism of Molecular Action in SARS-CoV-2.” Journal of Molecular and Genetic Medicine 14(5):1–8.

12) Kály-Kullai, K., M. Wittmann, Z. Noszticzius, and László Rosivall. 2020. “Can Chlorine Dioxide Prevent the Spreading of Coronavirus or Other Viral Infections? Medical Hypotheses.” Physiology International 107(1):1–11.

13) Kory, Pierre, Gianfranco Umberto Meduri, Joseph Varon, Jose Iglesias, and Paul E. Marik. 2021. “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.” American Journal of Therapeutics 28(3):e299–318.

14) Liu, Tao, Wenjia Liang, Haojie Zhong, Jianfeng He, Zihui Chen, Guanhao He, Tie Song, Shaowei Chen, Ping Wang, Jialing Li, Yunhua Lan, Mingji Cheng, Jinxu Huang, Jiwei Niu, Liang Xia, Jianpeng Xiao, Jianxiong Hu, Lifeng Lin, Qiong Huang, Zuhua Rong, Aiping Deng, Weilin Zeng, Jiansen Li, Xing Li, Xiaohua Tan, Min Kang, Lingchuan Guo, Zhihua Zhu, Dexin Gong, Guimin Chen, Moran Dong, and Wenjun Ma. 2020. “Risk Factors Associated with COVID-19 Infection: A Retrospective Cohort Study Based on Contacts Tracing.” Emerging Microbes and Infections 9(1):1546–53.

15) Long, Chunqin, Huaxiang Xu, Qinglin Shen, Xianghai Zhang, Bing Fan, Chuanhong Wang, Bingliang Zeng, Zicong Li, Xiaofen Li, and Honglu Li. 2020. “Diagnosis of the Coronavirus Disease (COVID-19): RRT-PCR or CT?” European Journal of Radiology 126:108961.

16) Lubbers, J. R., and J. R. Bianchine. 1984. “Effects of the Acute Rising Dose Administration of Chlorine Dioxide, Chlorate and Chlorite to Normal Healthy Adult Male Volunteers.” Journal of Environmental Pathology, Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 5:215—228.

17) Lubbers, Judith R., Sudha Chauhan, and Joseph R. Bianchine. 1981. “Controlled Clinical Evaluations of Chlorine Dioxide, Chlorite and Chlorate in Man.” Toxicological Sciences 1(4):334–38.

18) Madewell, Zachary J., Yang Yang, Ira M. Longini, Elizabeth Halloran, and Natalie E. Dean. 2020. “Household Transmission of SARS-CoV-2: A Systematic Review and Meta-Analysis.” JAMA Network Open 3(12):e2031756.

19) Martineau, Adrian R., and Nita G. Forouhi. 2020. “Vitamin D for COVID-19: A Case to Answer?” The Lancet Diabetes and Endocrinology 8:735–36.

20) Meo, S. A., D. C. Klonoff, and J. Akram. 2020. “Efficacy of Chloroquine and Hydroxychloroquine in the Treatment of COVID19.” European Review for Medical and Pharmacological Sciences 24(8):4539–47.

21) Noszticzius, Zoltán, Maria Wittmann, Kristóf Kály-Kullai, Zoltán Beregvári, István Kiss, László Rosivall, and János Szegedi. 2013. “Chlorine Dioxide Is a Size-Selective Antimicrobial Agent.” PLoS ONE 8(11):e79157.

22) Ogata, Norio. 2012. “Inactivation of Influenza Virus Haemagglutinin by Chlorine Dioxide: Oxidation of the Conserved Tryptophan 153 Residue in the Receptor-Binding Site.” Journal of General Virology 93:2558–63.

23) Olay Fuentes, Gabriela, Pablo Díaz Piedra, Ricardo Hernández Gómez, Daniel Cervantes-Villagrana, José Miguel Presno Bernal, and Luz Elena Alcántara Gómez. 2013. “Determinación de Intervalos de Referencia Para Química Clínica En Población Mexicana.” Revista Latinoamericana de Patología Clínica y Medicina de Laboratorio 60(1):43–51.

24) Osuagwu, Uchechukwu L., Chundung A. Miner, Dipesh Bhattarai, Khathutshelo Percy Mashige, Richard Oloruntoba, Emmanuel Kwasi Abu, Bernadine Ekpenyong, Timothy G. Chikasirimobi, Piwuna Christopher Goson, Godwin O. Ovenseri Ogbomo, Raymond Langsi, Deborah Donald Charwe, Tanko Ishaya, Obinna Nwaeze, and Kingsley Emwinyore Agho. 2021. “Misinformation about COVID-19 in Sub-Saharan Africa: Evidence from a Cross-Sectional Survey.” Health Security 19(1):44–56.

25) Park, Myungsun, Joungha Won, Byung Yoon Choi, and Justin C. Lee. 2020. “Optimization of Primer Sets and Detection Protocols for SARS-CoV-2 of Coronavirus Disease 2019 (COVID-19) Using PCR and Real-Time PCR.” Experimental and Molecular Medicine 52(6):963–77.

26) Rajasingham, Radha, Ananta S. Bangdiwala, Melanie R. Nicol, Caleb P. Skipper, Katelyn A. Pastick, Margaret L. Axelrod, Matthew F. Pullen, Alanna A. Nascene, Darlisha A. Williams, Nicole W. Engen, Elizabeth C. Okafor, Brian I. Rini, Ingrid A. Mayer, Emily G. McDonald, Todd C. Lee, Peter Li, Lauren J. MacKenzie, Justin M. Balko, Stephen J. Dunlop, Katherine H. Hullsiek, David R. Boulware, and Sarah M. Lofgren. 2021. “Hydroxychloroquine as Pre-Exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 72(11):e835–43.

27) Ramireddy, Archana, Harpriya Chugh, Kyndaron Reinier, Joseph Ebinger, Eunice Park, Michael Thompson, Eugenio Cingolani, Susan Cheng, Eduardo Marban, Christine M. Albert, and Sumeet S. Chugh. 2020. “Experience with Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for Qt Interval Monitoring.” Journal of the American Heart Association 9(12):e017144.

28) Rathi, Sahaj, Pranav Ish, Ashwini Kalantri, and Shriprakash Kalantri. 2020. “Hydroxychloroquine Prophylaxis for COVID-19 Contacts in India.” The Lancet Infectious Diseases 20(10):1118–19.

29) da Rosa Mesquita, Rodrigo, Luiz Carlos Francelino Silva Junior, Fernanda Mayara Santos Santana, Tatiana Farias de Oliveira, Rafaela Campos Alcântara, Gabriel Monteiro Arnozo, Etvaldo Rodrigues da Silva Filho, Aisla Graciele Galdino dos Santos, Euclides José Oliveira da Cunha, Saulo Henrique Salgueiro de Aquino, and Carlos Dornels Freire de Souza. 2021. “Clinical Manifestations of COVID-19 in the General Population: Systematic Review.” The Central European Journal of Medicine 133(377):382.

30) Rubin, Geoffrey A., Amar D. Desai, Zilan Chai, Aijin Wang, Qixuan Chen, Amy S. Wang, Cameron Kemal, Haajra Baksh, Angelo Biviano, Jose M. Dizon, Hirad Yarmohammadi, Frederick Ehlert, Deepak Saluja, David A. Rubin, John P. Morrow, Uma Mahesh R. Avula, Jeremy P. Berman, Alexander Kushnir, Mark P. Abrams, Jessica A. Hennessey, Pierre Elias, Timothy J. Poterucha, Nir Uriel, Christine J. Kubin, Elijah Lasota, Jason Zucker, Magdalena E. Sobieszczyk, Allan Schwartz, Hasan Garan, Marc P. Waase, and Elaine Y. Wan. 2021. “Cardiac Corrected QT Interval Changes among Patients Treated for COVID-19 Infection during the Early Phase of the Pandemic.” JAMA Network Open 4:1–14.

31) Shamshina, Julia L., and Robin D. Rogers. 2020. “Are Myths and Preconceptions Preventing Us from Applying Ionic Liquid Forms of Antiviral Medicines to the Current Health Crisis?” International Journal of Molecular Sciences 21(17):1–16.

32) Smith, David L., John-Paul Grenier, Catherine Batte, and Bradley Spieler. 2020. “A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic.” Radiology: Cardiothoracic Imaging 2(5):e200280.

33) Smith, Roger P., and Calvin C. Willhite. 1990. “Chlorine Dioxide and Hemodialysis.” Regulatory Toxicology and Pharmacology 11(1):42–62.

34) StataCorp. 2017. “Stata Statistical Software: Release 15.”

35) To, Kelvin Kai Wang, Owen Tak Yin Tsang, Wai Shing Leung, Anthony Raymond Tam, Tak Chiu Wu, David Christopher Lung, Cyril Chik Yan Yip, Jian Piao Cai, Jacky Man Chun Chan, Thomas Shiu Hong Chik, Daphne Pui Ling Lau, Chris Yau Chung Choi, Lin Lei Chen, Wan Mui Chan, Kwok Hung Chan, Jonathan Daniel Ip, Anthony Chin Ki Ng, Rosana Wing Shan Poon, Cui Ting Luo, Vincent Chi Chung Cheng, Jasper Fuk Woo Chan, Ivan Fan Ngai Hung, Zhiwei Chen, Honglin Chen, and Kwok Yung Yuen. 2020. “Temporal Profiles of Viral Load in Posterior Oropharyngeal Saliva Samples and Serum Antibody Responses during Infection by SARS-CoV-2: An Observational Cohort Study.” The Lancet Infectious Diseases 20(5):565– 74.

36) U.S. Environmental Protection Agency. 2000. “Toxicological Review of Chlorine Dioxide and Chlorite.” CAS Nos. 10049- 04-4 and 7758-19-2 (September):1–49.

37) Verdoia, M., and G. De Luca. 2021. “Potential Role Pf Hypovitaminosis D and Vitamin D Supplementation during COVID 19 Pandemic.” QJM: An International Journal of Medicine 114(1):3–10.

38) Wenham, Clare, Julia Smith, and Rosemary Morgan. 2020. “COVID-19: The Gendered Impacts of the Outbreak.” The Lancet 395(10227):846–48.

39) Xiang, Fei, Xiaorong Wang, Xinliang He, Zhenghong Peng, Bohan Yang, Jianchu Zhang, Qiong Zhou, Hong Ye, Yanling Ma, Hui Li, Xiaoshan Wei, Pengcheng Cai, and Wan Li Ma. 2020. “Antibody Detection and Dynamic Characteristics in Patients with Coronavirus Disease 2019.” Clinical Infectious Diseases 71(8):1930–34.

40) Yu, Xiaoqi, Dong Wei, Yongyan Chen, Donghua Zhang, and Xinxin Zhang. 2020. “Retrospective Detection of SARS-CoV-2 in Hospitalized Patients with Influenza-like Illness.” Emerging Microbes and Infections 9:1–12.

41) Zainol Rashid, Zetti, Siti Norlia Othman, Muttaqillah Najihan Abdul Samat, Umi Kalsom Ali, and Kon Ken Wong. 2020. “Diagnostic Performance of COVID-19 Serology Assays.” Malaysian Journal of Pathology 42(1):13–21.

VOLUME 04 ISSUE 08 AUGUST 2021